High Vista Strategies LLC Kura Oncology, Inc. Transaction History
High Vista Strategies LLC
- $255 Million
- Q3 2024
A detailed history of High Vista Strategies LLC transactions in Kura Oncology, Inc. stock. As of the latest transaction made, High Vista Strategies LLC holds 21,161 shares of KURA stock, worth $153,628. This represents 0.16% of its overall portfolio holdings.
Number of Shares
21,161
Previous 16,764
26.23%
Holding current value
$153,628
Previous $345,000
19.71%
% of portfolio
0.16%
Previous 0.14%
Shares
15 transactions
Others Institutions Holding KURA
# of Institutions
186Shares Held
81.7MCall Options Held
42.1KPut Options Held
34K-
Suvretta Capital Management, LLC New York, NY7.65MShares$55.6 Million5.88% of portfolio
-
Black Rock Inc. New York, NY6.97MShares$50.6 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA5.81MShares$42.2 Million4.92% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY5.41MShares$39.3 Million1.97% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY4.33MShares$31.4 Million3.05% of portfolio
About Kura Oncology, Inc.
- Ticker KURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 66,893,000
- Market Cap $486M
- Description
- Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...